These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28702148)

  • 41. Relationship of prostate-specific antigen and prostate volume in patients with biopsy proven benign prostatic hyperplasia.
    Hochberg DA; Armenakas NA; Fracchia JA
    Prostate; 2000 Dec; 45(4):315-9. PubMed ID: 11102956
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Can the intraprostatic concentration of epidermal growth factor influence the variance of serum prostate specific antigen levels in patients with benign prostatic hyperplasia?
    Di Silverio F; Sciarra A; Monti S; Casale P; Seccareccia F
    J Urol; 1999 Jan; 161(1):128-32. PubMed ID: 10037384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Correlation of IL-8 and IL-6 in prostatic fluid with serum prostate-specific antigen level in patients with benign prostatic hyperplasia complicated by prostatitis].
    Ren X; Wu C; Yu Q; Zhu F; Liu P; Zhang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):135-9. PubMed ID: 26806754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. "BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia.
    Mikolajczyk SD; Millar LS; Wang TJ; Rittenhouse HG; Wolfert RL; Marks LS; Song W; Wheeler TM; Slawin KM
    Urology; 2000 Jan; 55(1):41-5. PubMed ID: 10654892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationships between Prostate-Specific Antigen, Prostate Volume, and Components of Metabolic Syndrome in Healthy Korean Men.
    Byun HK; Sung YH; Kim W; Jung JH; Song JM; Chung HC
    Korean J Urol; 2012 Nov; 53(11):774-8. PubMed ID: 23185669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
    Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
    S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The relationship between serum PSA value and the weight of the inner gland of the prostate in the cases of benign prostatic hyperplasia].
    Wu B; Itoh Y; Saitoh M; Watanabe H
    Nihon Hinyokika Gakkai Zasshi; 1995 Oct; 86(10):1525-9. PubMed ID: 7474601
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer.
    Hammarsten J; Högstedt B
    Eur J Cancer; 2005 Dec; 41(18):2887-95. PubMed ID: 16243513
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio.
    Kaynar M; Yildirim ME; Gul M; Kilic O; Ceylan K; Goktas S
    Cancer Biomark; 2015; 15(3):317-23. PubMed ID: 25586096
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between serum prostate-specific antigen and prostate volume in Korean men with benign prostatic hyperplasia: a multicentre study.
    Chung BH; Hong SJ; Cho JS; Seong DH
    BJU Int; 2006 Apr; 97(4):742-6. PubMed ID: 16536765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].
    Bantis A; Zissimopoulos A; Kalaytzis C; Giannakopoulos S; Sountoulides P; Agelonidou E; Voudalikakis C; Touloupidis S
    Hell J Nucl Med; 2007; 10(2):138-43. PubMed ID: 17684595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prostate-specific antigen in patients with benign prostatic hyperplasia].
    Goncalves F; Kausitz J; Bárdos A; Miklosi M
    Rozhl Chir; 1994 Sep; 73(6):291-3. PubMed ID: 7536350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibitory effects of Tripterygium wilfordii multiglycoside on benign prostatic hyperplasia in rats.
    Shen HN; Xu Y; Jiang ZZ; Huang X; Zhang LY; Wang T
    Chin J Nat Med; 2015 Jun; 13(6):421-7. PubMed ID: 26073338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men.
    Yin Z; Yang JR; Rao JM; Song W; Zhou KQ
    Asian J Androl; 2015; 17(5):826-30. PubMed ID: 25677137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Investigating the link between benign prostatic hypertrophy, BMI and type 2 diabetes mellitus.
    Nayak BS; Sinanan K; Sharma S; Shripat V; Sidat R; Siddiqui S; Sieunarine N; Sieunarine S
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S627-S630. PubMed ID: 28433616
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The changes of prostate specific antigen (PSA) after treatment with alpha 1-adrenergic receptor antagonists in men with 4.0-9.9 ng/ml PSA level--a study for comparison of benign prostatic hyperplasia/lower urinary tract symptom (BPH/LUTS) and prostate cancer].
    Hanai T; Matsumoto S; Shouji S; Usui Y; Tang XY; Kato Y; Iguchi M; Uemura H; Terachi T
    Hinyokika Kiyo; 2009 Apr; 55(4):187-91. PubMed ID: 19462822
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):145-54. PubMed ID: 9135695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Can benign prostatic hyperplasia be identified in the primary care setting using only simple tests? Results of the Diagnosis IMprovement in PrimAry Care Trial.
    Carballido J; Fourcade R; Pagliarulo A; Brenes F; Boye A; Sessa A; Gilson M; Castro R
    Int J Clin Pract; 2011 Sep; 65(9):989-96. PubMed ID: 21733048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of prostatic disease and prostatic manipulations on the concentration of prostate-specific antigen.
    Walz PH; Schoppmann T; Büscher C; Ennen J; Schriewer H
    Eur Urol; 1992; 22(1):20-6. PubMed ID: 1385141
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia.
    Stephan C; Lein M; Jung K; Schnorr D; Loening SA
    Cancer; 1997 Jan; 79(1):104-9. PubMed ID: 8988733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.